Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Receivables - Other (2018 - 2022)

NovaBridge Biosciences (NBP) has disclosed Receivables - Other for 5 consecutive years, with $1.2 million as the latest value for Q4 2022.

  • On a quarterly basis, Receivables - Other fell 76.58% to $1.2 million in Q4 2022 year-over-year; TTM through Dec 2022 was $1.2 million, a 76.58% decrease, with the full-year FY2022 number at $1.2 million, down 96.92% from a year prior.
  • Receivables - Other was $1.2 million for Q4 2022 at NovaBridge Biosciences, down from $4.9 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $34.3 million in Q4 2020 to a low of $1.2 million in Q4 2022.
  • A 5-year average of $8.9 million and a median of $2.3 million in 2019 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: surged 1392.78% in 2020, then crashed 85.6% in 2021.
  • NovaBridge Biosciences' Receivables - Other stood at $1.6 million in 2018, then skyrocketed by 44.48% to $2.3 million in 2019, then soared by 1392.78% to $34.3 million in 2020, then plummeted by 85.6% to $4.9 million in 2021, then crashed by 76.58% to $1.2 million in 2022.
  • Per Business Quant, the three most recent readings for NBP's Receivables - Other are $1.2 million (Q4 2022), $4.9 million (Q4 2021), and $34.3 million (Q4 2020).